Cargando…
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity
C.B-17 severe combined immune deficient (SCID) mice, which lack functional B and T lymphocytes, allow xenografts and, therefore, can be used to study the biology of human malignancies. Two different human B cell lymphoma cell lines, SU-DHL-4 and OCI-Ly8, which both harbor the t(14;18) chromosomal tr...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2118875/ https://www.ncbi.nlm.nih.gov/pubmed/1711560 |
Ejemplares similares
-
Cytokine-induced killer cells promote antitumor immunity
por: Jiang, Jingting, et al.
Publicado: (2013) -
Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model
por: Mori, F, et al.
Publicado: (2012) -
Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2017) -
Correction: Cytokine-induced killer cell delivery enhances the antitumor activity of oncolytic reovirus
por: Zhao, Xing, et al.
Publicado: (2018) -
Immunophenotype and antitumor activity of cytokine-induced killer cells from patients with hepatocellular carcinoma
por: Yang, Chan-Keng, et al.
Publicado: (2023)